CervoMed (CRVO) News Today → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free CRVO Stock Alerts $18.22 -0.47 (-2.51%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 9:16 PM | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Sees Significant Growth in Short InterestCervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 126,500 shares, a growth of 144.2% from the April 30th total of 51,800 shares. Currently, 2.4% of the company's stock are sold short. Based on an average daily volume of 24,600 shares, the short-interest ratio is presently 5.1 days.May 20, 2024 | markets.businessinsider.comCervoMed Appoints William Elder To Succeed William Tanner As CFOMay 20, 2024 | globenewswire.comCervoMed to Appoint William Elder as Chief Financial OfficerMay 16, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)May 15, 2024 | msn.comCRVO Stock Earnings: CervoMed Misses EPS, Beats Revenue for Q1 2024May 15, 2024 | globenewswire.comCervoMed Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 11, 2024 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Sees Large Growth in Short InterestCervoMed Inc. (NASDAQ:CRVO - Get Free Report) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 51,800 shares, an increase of 101.6% from the April 15th total of 25,700 shares. Based on an average trading volume of 33,100 shares, the short-interest ratio is currently 1.6 days. Approximately 1.1% of the company's stock are sold short.May 3, 2024 | marketbeat.comCwm LLC Purchases Shares of 38,253 CervoMed Inc. (NASDAQ:CRVO)Cwm LLC acquired a new position in shares of CervoMed Inc. (NASDAQ:CRVO - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 38,253 shares of the company's stock, valueApril 30, 2024 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Short Interest Up 24.8% in AprilCervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 25,700 shares, a growth of 24.8% from the March 31st total of 20,600 shares. Based on an average trading volume of 29,500 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.7% of the company's stock are short sold.April 19, 2024 | wsj.comCervoMed Inc.April 15, 2024 | benzinga.comCRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24April 12, 2024 | marketbeat.comFY2024 EPS Estimates for CervoMed Inc. Raised by Zacks Small Cap (NASDAQ:CRVO)CervoMed Inc. (NASDAQ:CRVO - Free Report) - Analysts at Zacks Small Cap boosted their FY2024 EPS estimates for CervoMed in a note issued to investors on Wednesday, April 10th. Zacks Small Cap analyst D. Bautz now anticipates that the company will earn ($1.13) per share for the year, up from theirApril 11, 2024 | marketbeat.comZacks Small Cap Weighs in on CervoMed Inc.'s Q1 2024 Earnings (NASDAQ:CRVO)CervoMed Inc. (NASDAQ:CRVO - Free Report) - Equities research analysts at Zacks Small Cap issued their Q1 2024 earnings estimates for CervoMed in a research report issued on Wednesday, April 10th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings per share of ($0.46April 10, 2024 | uk.investing.comCervoMed shares target raised by Canaccord on positive trial outlookApril 10, 2024 | finance.yahoo.comCRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24…April 8, 2024 | marketbeat.comCanaccord Genuity Group Increases CervoMed (NASDAQ:CRVO) Price Target to $65.00Canaccord Genuity Group raised their target price on shares of CervoMed from $50.00 to $65.00 and gave the stock a "buy" rating in a research note on Monday.April 3, 2024 | seekingalpha.comCervoMed: H2 2024 Data For DLB Program A Major Inflection PointApril 1, 2024 | globenewswire.comCervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesMarch 30, 2024 | uk.investing.comCervoMed secures $50 million in private placementMarch 28, 2024 | globenewswire.comCervoMed to Participate in Upcoming Investor ConferencesMarch 28, 2024 | globenewswire.comCervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare InvestorsMarch 21, 2024 | marketbeat.comCervoMed (CRVO) Set to Announce Quarterly Earnings on FridayCervoMed (NASDAQ:CRVO) will be releasing earnings on Friday, March 22, Yahoo Finance reports.March 15, 2024 | marketbeat.comShort Interest in CervoMed Inc. (NASDAQ:CRVO) Declines By 17.5%CervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 29th, there was short interest totalling 33,500 shares, a decline of 17.5% from the February 14th total of 40,600 shares. Based on an average daily trading volume, of 24,000 shares, the short-interest ratio is currently 1.4 days. Approximately 1.0% of the shares of the company are short sold.March 12, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Acquires Shares of 199,347 CervoMed Inc. (NASDAQ:CRVO)Adage Capital Partners GP L.L.C. acquired a new stake in shares of CervoMed Inc. (NASDAQ:CRVO - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 199,347 shares of the company's stock, valued at aMarch 9, 2024 | finance.yahoo.comCervoMed Inc.'s (NASDAQ:CRVO): Top Key Executive Sylvie Gregoire is the most bullish insider, and their stock value gained 29% last weekMarch 7, 2024 | uk.investing.comCervoMed reports promising dementia treatment trial resultsMarch 5, 2024 | globenewswire.comCervoMed Announces Presentation of Biomarker Data from the AscenD-LB Phase 2a Trial and Preclinical Data Supporting Potential of Neflamapimod in Tau-Mediated Disease at AD/PD ™ 2024February 25, 2024 | msn.comCervoMed (CRVO) Price Target Increased by 97.06% to 34.17February 21, 2024 | finance.yahoo.comCervoMed to Participate in the BIO CEO and Investor ConferenceFebruary 21, 2024 | globenewswire.comCervoMed to Participate in the BIO CEO and Investor ConferenceFebruary 15, 2024 | marketbeat.comCanaccord Genuity Group Begins Coverage on CervoMed (NASDAQ:CRVO)Canaccord Genuity Group initiated coverage on shares of CervoMed in a report on Thursday. They set a "buy" rating and a $50.00 target price for the company.February 12, 2024 | finance.yahoo.comCervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy BodiesFebruary 9, 2024 | proactiveinvestors.comCervoMed appoints drug development veteran Dr. Joshua Boger as Chairman of the BoardFebruary 8, 2024 | msn.comCervoMed Appoints New Chair and Presents at Conference 67February 8, 2024 | msn.comCervoMed Names Joshua Boger as New Board ChairFebruary 7, 2024 | finance.yahoo.comCervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the BoardFebruary 5, 2024 | finance.yahoo.comCervoMed to Participate in the Emerging Growth Conference 67February 3, 2024 | msn.comCervoMed Signs Key Material Definitive AgreementFebruary 3, 2024 | msn.comCervoMed Announces Executive Leadership Agreements UpdateJanuary 5, 2024 | finance.yahoo.comCervoMed to Participate in the Emerging Growth Conference 66November 17, 2023 | finance.yahoo.comWe're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn RateNovember 16, 2023 | finance.yahoo.comCRVO: Publications Highlight Neflamapimod as Potential Disease-Modifying Therapy for Major Dementias…November 13, 2023 | finanznachrichten.deCervoMed Inc.: CervoMed Reports Third Quarter 2023 Financial Results and Business HighlightsNovember 13, 2023 | finance.yahoo.comCervoMed Reports Third Quarter 2023 Financial Results and Business HighlightsNovember 10, 2023 | morningstar.comCervoMed Inc CRVOOctober 30, 2023 | finance.yahoo.comCRVO: New Data from Phase 2a Trial Presented at CTAD…October 25, 2023 | finance.yahoo.comCervoMed Announces Oral Presentation at CTAD 2023 Highlighting Learnings from Phase 2a Which Optimized the Design of the Phase 2b Clinical Study of Neflamapimod in Dementia with Lewy BodiesOctober 24, 2023 | finance.yahoo.comCervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major DementiasOctober 18, 2023 | finance.yahoo.comCervoMed Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy BodiesOctober 5, 2023 | finance.yahoo.comCervoMed to Present at the 2023 Roth Healthcare Opportunities Conference Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Log Into Marc's $5,000 System Today (Ad)New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. CRVO Media Mentions By Week CRVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVO News Sentiment▼1.880.87▲Average Medical News Sentiment CRVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVO Articles This Week▼41▲CRVO Articles Average Week Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SGMT News INCR News CNTX News CTMX News SYRS News CRVS News RENB News OPTN News IMAB News RNAC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
